5d 1m 3m 1y 5y 10y
There is research on this stock available only to PRO subscribers.
There are no Transcripts on NYMX.
GlobeNewswire (Feb 5, 2014)
GlobeNewswire (Jan 28, 2014)
GlobeNewswire (Jan 13, 2014)
GlobeNewswire (Nov 14, 2013)
Nymox Reports Update and Positive Safety Data for Phase 3 NX02-0022 Reinjection Study of NX-1207 for BPHGlobeNewswire (Nov 11, 2013)
NYMX vs. ETF Alternatives
Nymox Pharmaceutical Corporation is a biopharmaceutical company, engaged in R&D & sale of drugs for the aging population. It offers products such as AlzheimAlert, NicAlert & TobacAlert & is developing NX-1207 for benign prostatic hyperplasia.